Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear pore associated protein 1 pseudogene 9 (NPAP1P9) is a human pseudogene, meaning it is a DNA sequence with high similarity to a functional gene (in this case, likely *NPAP1*, which encodes a nuclear pore-associated protein) but has lost the capacity to encode a functional protein[2]. Pseudogenes often arise from gene duplication or retrotransposition events followed by disabling mutations[2][6]. While most pseudogenes are considered genomic "fossils," emerging research suggests that some can have biological roles, such as regulating their parent gene or acting as miRNA decoys or sources of regulatory RNAs in certain contexts[4][6]. However, there is no evidence that NPAP1P9 produces a protein or has a direct role in disease, biological pathways, or drug response. It is not a recognized therapeutic target.
None applicable. As there are no drugs targeting NPAP1P9, mechanisms of action are not defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear pore associated protein 1 pseudogene 9 (NPAP1P9).